Literature DB >> 9540022

Cognitive function in an elderly population with persistent impaired glucose tolerance.

M Vanhanen1, K Koivisto, J Kuusisto, L Mykkänen, E L Helkala, T Hänninen, P Riekkinen, H Soininen, M Laakso.   

Abstract

OBJECTIVE: To study cognitive function in an elderly population with persistent impaired glucose tolerance (IGT). RESEARCH DESIGN AND METHODS: Fasting and postload 2-h plasma glucose and insulin levels were determined at baseline in a population-based sample of 1,300 people and repeated an average of 3.5 years later in 980 subjects. At follow-up, cognitive function was evaluated in subjects with persistent normal glucose tolerance (NGT; n = 506) and IGT (n = 80) with a brief neuropsychological test battery.
RESULTS: Subjects with persistent IGT scored lower in the Mini-Mental State Examination (MMSE) and in the Buschke Selective Reminding Test long-term memory scores. Multiple linear regression analysis revealed that age, education, and insulin levels (either fasting or 2-h value) were associated with the MMSE score in subjects with persistent IGT. Other potential risk factors for impaired cognitive function were not significantly associated with the MMSE score.
CONCLUSIONS: Our study showed that persistent IGT in the elderly is associated with mildly impaired cognitive function, and hyperinsulinemia may account for this association.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9540022     DOI: 10.2337/diacare.21.3.398

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  43 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

3.  Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance.

Authors:  H Bruehl; V Sweat; J Hassenstab; V Polyakov; A Convit
Journal:  J Clin Exp Neuropsychol       Date:  2010-06       Impact factor: 2.475

Review 4.  Obesity, insulin resistance, and Alzheimer's disease.

Authors:  Kerry L Hildreth; Rachael E Van Pelt; Robert S Schwartz
Journal:  Obesity (Silver Spring)       Date:  2012-02-07       Impact factor: 5.002

Review 5.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

6.  Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes.

Authors:  Olivia I Okereke; Michael N Pollak; Frank B Hu; Susan E Hankinson; Dennis J Selkoe; Francine Grodstein
Journal:  Psychoneuroendocrinology       Date:  2008-02-07       Impact factor: 4.905

7.  Exploring effects of type 2 diabetes on cognitive functioning in older adults.

Authors:  Sophie E Yeung; Ashley L Fischer; Roger A Dixon
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

8.  Cognitive decline and cardiometabolic risk among Hispanic and non-Hispanic white adults in the San Luis Valley Health and Aging Study.

Authors:  Kerry L Hildreth; Jim Grigsby; Lucinda L Bryant; Pamela Wolfe; Judith Baxter
Journal:  J Behav Med       Date:  2013-01-18

9.  A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus.

Authors:  E van den Berg; Y D Reijmer; J de Bresser; R P C Kessels; L J Kappelle; G J Biessels
Journal:  Diabetologia       Date:  2009-10-31       Impact factor: 10.122

10.  Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors.

Authors:  Massimo Musicco; Katie Palmer; Giovanna Salamone; Federica Lupo; Roberta Perri; Serena Mosti; Gianfranco Spalletta; Fulvia di Iulio; Carla Pettenati; Luca Cravello; Carlo Caltagirone
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.